Thalys Medical Technology Group Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,762.5 million compared to CNY 1,825.97 million a year ago. Revenue was CNY 1,762.5 million compared to CNY 1,825.97 million a year ago.

Net loss was CNY 5.01 million compared to net income of CNY 0.857678 million a year ago. Basic loss per share from continuing operations was CNY 0.02. Diluted loss per share from continuing operations was CNY 0.02.